We are live on ! Find out more
FIM

Freedom Investment Management Portfolio holdings

AUM $359M
1-Year Est. Return 23.01%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+23.01%
3 Year Est. Return
+68.48%
5 Year Est. Return
+80.23%
10 Year Est. Return
+247.18%
AUM
$1.29B
AUM Growth
+$377M
Cap. Flow
+$357M
Cap. Flow %
27.71%
Top 10 Hldgs %
15.67%
Holding
932
New
319
Increased
251
Reduced
265
Closed
96
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAVA icon
776
Endava
DAVA
$157M
$213K 0.02%
+2,514
New +$210K
NET icon
777
Cloudflare
NET
$112B
$213K 0.02%
+3,031
New +$234K
COLL icon
778
Collegium Pharmaceutical
COLL
$856M
$212K 0.02%
+8,942
New +$212K
CMD
779
DELISTED
Cantel Medical Corporation
CMD
$211K 0.02%
+2,649
New +$207K
EVR icon
780
Evercore
EVR
$11.6B
$210K 0.02%
1,594
-484
-23% -$59.1K
BMI icon
781
Badger Meter
BMI
$3.86B
$209K 0.02%
+2,241
New +$226K
RMBS icon
782
Rambus
RMBS
$11B
$208K 0.02%
10,722
-788
-7% -$15.8K
QED
783
DELISTED
IQ Hedge Event-Driven Tracker ETF
QED
$207K 0.02%
+8,799
New +$209K
LGND icon
784
Ligand Pharmaceuticals
LGND
$5.86B
$206K 0.02%
+2,169
New +$205K
ASTE icon
785
Astec Industries
ASTE
$990M
$204K 0.02%
+2,701
New +$183K
EWW icon
786
iShares MSCI Mexico ETF
EWW
$1.89B
$203K 0.02%
4,629
-32
-0.7% -$1.38K
IART icon
787
Integra LifeSciences
IART
$1.34B
$203K 0.02%
+2,938
New +$199K
INO icon
788
Inovio Pharmaceuticals
INO
$79M
$202K 0.02%
+1,812
New +$238K
SUPN icon
789
Supernus Pharmaceuticals
SUPN
$2.73B
$202K 0.02%
+7,727
New +$216K
DELL icon
790
Dell
DELL
$301B
$201K 0.02%
+4,498
New +$184K
HALO icon
791
Halozyme
HALO
$11.6B
$201K 0.02%
+4,823
New +$220K
MNST icon
792
Monster Beverage
MNST
$89.6B
$201K 0.02%
+8,808
New +$197K
SKT icon
793
Tanger
SKT
$4.45B
$200K 0.02%
+13,215
New +$195K
YYY icon
794
Amplify CEF High Income ETF
YYY
$744M
$196K 0.02%
+11,739
New +$193K
AMX icon
795
America Movil
AMX
$69.4B
$194K 0.02%
14,304
-253
-2% -$3.48K
MDRX
796
DELISTED
Veradigm Inc. Common Stock
MDRX
$191K 0.01%
12,718
+1,761
+16% +$28.2K
JNCE
797
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$189K 0.01%
+18,419
New +$202K
GLRE icon
798
Greenlight Captial
GLRE
$505M
$187K 0.01%
+21,530
New +$176K
TEF
799
DELISTED
Telefonica
TEF
$186K 0.01%
+46,128
New +$188K
HIMX
800
Himax Technologies
HIMX
$2.63B
$181K 0.01%
+13,283
New +$155K

Similar funds

Freedom Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Freedom Investment Management held 932 positions worth $1.29B, up 41% from $910M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Freedom Investment Management deployed $357M of net new capital in Q1 2021, opening 319 new positions and adding to 251 existing holdings. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 220,570 shares worth $20.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $18M trimmed.

  • Freedom Investment Management's largest Q1 2021 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 220,570 shares worth $20.2M.
  • Freedom Investment Management added most to Fidelity MSCI Financials Index ETF in Q1 2021, an estimated $15.8M increase.
  • Freedom Investment Management's biggest Q1 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $18M.
  • Freedom Investment Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2021, selling an estimated $6.84M.
  • Freedom Investment Management's ten largest holdings make up 16% of its $1.29B portfolio in Q1 2021.
  • Freedom Investment Management opened 319 new positions and closed 96 in Q1 2021.
  • Freedom Investment Management's portfolio value rose 41% quarter-over-quarter to $1.29B.

Based on Freedom Investment Management's 13F filing for Q1 2021, filed 14 May 2021.